Casey C. Kopczynski
Keine laufenden Positionen mehr
Karriereverlauf von Casey C. Kopczynski
Ehemalige bekannte Positionen von Casey C. Kopczynski
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AERIE PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 22.06.2005 | 01.03.2022 |
| Gründer | 22.06.2005 | 21.11.2022 | |
| Corporate Officer/Principal | 01.03.2022 | 21.11.2022 | |
| Biotech Initiative LLC | Corporate Officer/Principal | 01.01.2002 | - |
Ercole Biotech, Inc.
 Ercole Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sarepta Therapeutics, Inc., Ercole Biotech, Inc. develops splice switching drugs for the treatment of major human diseases. The company is based in Research Triangle Park, NC. The company was founded by Jorn Gorlach. Ercole Biotech was acquired by Sarepta Therapeutics, Inc. on March 20, 2008 for $8.25 million. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2003 | - |
| EXELIXIS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1996 | 01.01.2002 |
Ausbildung von Casey C. Kopczynski
| Indiana University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
Operativ
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 2 |
| Founder | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| EXELIXIS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
Ercole Biotech, Inc.
Ercole Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sarepta Therapeutics, Inc., Ercole Biotech, Inc. develops splice switching drugs for the treatment of major human diseases. The company is based in Research Triangle Park, NC. The company was founded by Jorn Gorlach. Ercole Biotech was acquired by Sarepta Therapeutics, Inc. on March 20, 2008 for $8.25 million. | Commercial Services |
| Biotech Initiative LLC |
- Börse
- Insiders
- Casey C. Kopczynski
- Erfahrung
